Arbutus Biopharma Corp (NASDAQ:ABUS)

2.24
Delayed Data
As of May 25
 +0.06 / +2.74%
Today’s Change
1.93
Today|||52-Week Range
6.50
-42.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$361.4M

Company Description

Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Contact Information

Arbutus Biopharma Corp.
701 Veterans Circle
Warminster Pennsylvania 18974
P:(267) 469-0914
Investor Relations:

Employees

Shareholders

Other institutional19.26%
Individual stakeholders13.36%
Mutual fund holders10.26%

Top Executives

William H. CollierPresident, Chief Executive Officer & Director
David C. HastingsChief Financial & Accounting Officer
Michael J. SofiaChief Scientific Officer
Elizabeth HowardSecretary, Chief Compliance Officer & EVP
Michael J. McElhaughChief Business Officer